Astria Therapeutics, Inc. today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will present a corporate overview and provide information on lead program STAR-0215 at the following upcoming virtual investor conferences: H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021.
September 10, 2021
· 1 min read